Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study - Anjum, Mariam; Ariansen, Inger; Hjellvik, Vidar; Selmer, Randi; Kjerpeseth, Lars J; Skovlund, Eva; Myrstad, Marius; Ellekjær, Hanne; Christophersen, Ingrid E; Tveit, Arnljot; Berge, Trygve (European heart journal, 2024)
Keywords: Anticoagulants; Atrial Fibrillation - complications; Atrial Fibrillation - drug therapy; Atrial Fibrillation - epidemiology; Brain Ischemia - epidemiology; Brain Ischemia - etiology; Brain Ischemia - prevention & control; Hemorrhage - chemically induced; Hemorrhage - complications; Hemorrhage - epidemiology; Humans; Intracranial Hemorrhages - chemically induced; Intracranial Hemorrhages - epidemiology; Ischemic Stroke - chemically induced; Ischemic Stroke - complications; Ischemic Stroke - drug therapy; Risk Assessment; Risk Factors; Stroke - epidemiology; Stroke - etiology; Stroke - prevention & control; Prevention; Oral anticoagulation; Stroke risk; Atrial fibrillation; Bleeding